 |
|
Why are so few HIV/AIDS trials conducted in Africa?
September 30, 2005Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution BMJ Volume 331, pp 742-6
People in sub-Saharan Africa carry the heaviest burden of HIV and AIDS, yet very few trials have been conducted on the African continent over the past two decades, say researchers in this week's BMJ.
This study confirms previous findings that HIV/AIDS trials are under-represented in sub-Saharan research and suggests that publication of trial results continues to be driven by researchers external to the continent.
The team identified and mapped all randomised controlled trials on HIV and AIDS conducted wholly or partly in Africa and reported before 2004.
After extensive searching, they identified 77 trials published or reported from 1987 to 2003.
Most of the trials were funded by government agencies outside Africa, pharmaceutical companies and international non-government or inter-government organisations. Few principal investigators were based in African countries and there was no mention of ethical approval or informed consent in 19 and 17 trials, respectively.
The relatively small number of HIV/AIDS trials conducted in Africa is not commensurate with the burden of disease, say the authors. This may reflect a lack of economic ability, political will, or research capacity.
Geographical mapping as an adjunct to prospective trial registration is a useful tool for researchers and decision makers to track existing and future trials, they conclude.
BMJ-British Medical Journal
After extensive searching, they identified 77 trials published or reported from 1987 to 2003.
Most of the trials were funded by government agencies outside Africa, pharmaceutical companies and international non-government or inter-government organisations. Few principal investigators were based in African countries and there was no mention of ethical approval or informed consent in 19 and 17 trials, respectively.
The relatively small number of HIV/AIDS trials conducted in Africa is not commensurate with the burden of disease, say the authors. This may reflect a lack of economic ability, political will, or research capacity.
Geographical mapping as an adjunct to prospective trial registration is a useful tool for researchers and decision makers to track existing and future trials, they conclude.
BMJ-British Medical Journal
More Hiv/aids Trials Current Events and Hiv/aids Trials News Articles
|
VIRXSYS TO INITIATE PHASE I TRIALS FOR HIV/AIDS TREATMENT.: An article from: Biotech Business by Worldwide Videotex (Publisher) This digital document is an article from Biotech Business, published by Worldwide Videotex on April 1, 2003. The length of the article is 993 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: VIRXSYS TO INITIATE PHASE I TRIALS FOR HIV/AIDS TREATMENT. Publication: Biotech Business (Newsletter) Date: April 1, 2003 Publisher: Worldwide Videotex Volume: 16 Issue: 4 Page: NA Distributed by Thomson Gale | |
|
Male circumcision and reduction of risk of HIV infection.(ROUND UP: HIV/AIDS)(human immunovirus)(stopping disease transmission ): An article from: Reproductive Health Matters by Gale Reference Team (Author) This digital document is an article from Reproductive Health Matters, published by Thomson Gale on November 1, 2006. The length of the article is 499 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Male circumcision and reduction of risk of HIV infection.(ROUND UP: HIV/AIDS)(human immunovirus)(stopping disease transmission ) Author: Gale Reference Team Publication: Reproductive Health Matters (Magazine/Journal) Date: November 1, 2006 Publisher: Thomson Gale Volume: 14 Issue: 28 Page: 205(2) Distributed by Thomson... | |
 |
Methodological Challenges in Biomedical HIV Prevention Trials by Committee on the Methodological Challenges in HIV Prevention Trials (Author), Stephen W. Lagakos (Editor), Alicia R. Gable (Editor) The number of people infected with HIV or living with AIDS is increasing at unprecedented rates as various scientists, organizations, and institutions search for innovative solutions to combating and preventing the disease. At the request of the Bill & Melinda Gates Foundation, Methodological Challenges in Biomedical HIV Prevention Trials addresses methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials. This book recommends a number of ways to improve the design, monitoring, and analysis of late-stage clinical trials that evaluate nonvaccine biomedical interventions. The objectives include identifying a beneficial method of intervention, enhancing quantification of the impact, properly... |
 |
AIDS Clinical Trials by Dianne M. Finkelstein (Editor), David A. Schoenfeld (Editor) AIDS CLINICAL TRIALS Edited by Dianne M. Finkelstein and David A. Schoenfeld Conducting trials for new drugs or regimens for the treatment of HIV or AIDS presents unique challenges to statisticians and clinical investigators. Not only must they have a clear understanding of the relevant regulatory issues and methods of statistical analysis, but they must also deal with various medical and social pressures that further complicate the design and implementation of clinical trials. AIDS Clinical Trials addresses the critical scientific, clinical, and regulatory issues involved in AIDS drug development and evaluation. The book provides the reader with detailed guidelines on the essential statistical methods for data analysis in AIDS clinical trials, and helps foster an understanding of the... |
 |
Case Studies in Ethics and HIV Research by Sana Loue (Editor), Earl C. Pike (Editor) There has been a consistent interest in ethical issues arising in the context of HIV research. Ongoing international and multi-site studies and the continuing search for an HIV vaccine continue to prompt examination of how this research is conducted, how participants are engaged in the studies, and the obligations of the researchers to individual participants and their communities during the course of and following the conclusion of the research. Each chapter is authored primarily by one of the editors (secondarily by the other) and is accompanied by one to two case studies. Each case study has been authored by an HIV/AIDS researcher with experience in the subject matter of the chapter. The case studies will focus on an actual ethical dilemma encountered by the researcher, with... |
|
Predictors of medication adherence in an AIDS clinical trial: patient and clinician perceptions.(Clinical report): An article from: Health and Social Work by Lisa E. Cox (Author) This digital document is an article from Health and Social Work, published by National Association of Social Workers on November 1, 2009. The length of the article is 5047 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. From the author: KEY WORDS: adherence; clinical trials; compliance; health belief model; HIV/AIDS Citation Details Title: Predictors of medication adherence in an AIDS clinical trial: patient and clinician perceptions.(Clinical report) Author: Lisa E. Cox Publication: Health and Social Work (Magazine/Journal) Date: November 1, 2009 Publisher: National Association of Social Workers Volume: 34 ... | |
|
AIDS clinical trials: talking it over. (includes comments by AIDS patients) (pamphlet): An article from: Pamphlet by: National Institute of Allergy and Infectious Diseases by National Institute of Allergy and Infectious Diseases (Publisher) This digital document is an article from Pamphlet by: National Institute of Allergy and Infectious Diseases, published by National Institute of Allergy and Infectious Diseases on August 1, 1989. The length of the article is 7011 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: AIDS clinical trials: talking it over. (includes comments by AIDS patients) (pamphlet) Publication: Pamphlet by: National Institute of Allergy and Infectious Diseases (Pamphlet) Date: August 1, 1989 Publisher: National Institute of Allergy and Infectious Diseases Page: p1(28) Article... | |
|
Interim Results of AIDS Vaccine Trial Anticipated. (Trial Likely To Continue).: An article from: Internal Medicine News by Nancy Walsh (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on November 15, 2001. The length of the article is 614 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Interim Results of AIDS Vaccine Trial Anticipated. (Trial Likely To Continue). Author: Nancy Walsh Publication: Internal Medicine News (Magazine/Journal) Date: November 15, 2001 Publisher: International Medical News Group Volume: 34 Issue: 22 Page: 16(1) Article Type: Product/Service Evaluation Distributed by Thomson... | |
 |
Quality of Life Assessment in Clinical Trials: Methods and Practice by Maurice J. Staquet (Editor), Ron D. Hays (Editor), Peter M. Fayers (Editor) Researchers in all clinical fields are becoming increasingly aware of the importance of quality of life measurements in judging the efficacy of a given treatment, and it is becoming more common for psychological criteria to play an important role in the evaluation of therapies. In the past ten years a number of methods have been developed for carrying out such assessments. Quality of life research does however use special statistical methods which might well be unfamiliar to the clinician. Quality of Life Assessment in Clinical Trials: Methods and Practice explores these methods in a non-mathematical manner, comparing and contrasting the tools available to the clinician, and highlighting any potential pitfalls. It describes the methods used to collect and analyse quality of life data. The... |
|
Clinical trial information.(various reports on AIDS treatment research): An article from: HIV Treatment: ALERTS! by The Center for AIDS: Hope & Remembrance Project (Publisher) This digital document is an article from HIV Treatment: ALERTS!, published by The Center for AIDS: Hope & Remembrance Project on September 1, 2002. The length of the article is 654 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Clinical trial information.(various reports on AIDS treatment research) Publication: HIV Treatment: ALERTS! (Newsletter) Date: September 1, 2002 Publisher: The Center for AIDS: Hope & Remembrance Project Page: 10(1) Distributed by Thomson... |
| © 2009 BrightSurf.com |